{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:14:48Z","timestamp":1790403288926,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.clinbiochem.2009.11.002","type":"journal-article","created":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T00:20:02Z","timestamp":1257985202000},"page":"442-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Soluble receptor for advanced glycation end products in physiological and pathological pregnancy"],"prefix":"10.1016","volume":"43","author":[{"given":"Anna","family":"Germanov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Kouck\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zden\u011bk","family":"H\u00e1jek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton\u00edn","family":"Pa\u0159\u00edzek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Zima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Kalousov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2009.11.002_bib1","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI118175","volume":"96","author":"Schmidt","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib2","first-page":"99","article-title":"The biology of the receptor for advanced glycation end products and its ligand","volume":"1498","author":"Schmidt","year":"2000","journal-title":"BBA \u2013 Mol. Cell. Res."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib3","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.ATV.0000160342.20342.00","article-title":"Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in non diabetic men","volume":"25","author":"Falcone","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/sj.gene.6363861","article-title":"RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response","volume":"3","author":"Hofmann","year":"2002","journal-title":"Genes Immun."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1053\/j.ajkd.2005.12.028","article-title":"Soluble receptor for advanced glycation end products in patients with decreased renal function","volume":"47","author":"Kalousov\u00e1","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.ATV.0000164804.05324.8b","article-title":"Soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease. The next C-reactive protein","volume":"25","author":"Hudson","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1023\/B:PHAM.0000032992.75423.9b","article-title":"RAGE: a novel target for drug intervention in diabetic vascular disease","volume":"21","author":"Hudson","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1186\/ar1749","article-title":"Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control","volume":"7","author":"Pullerits","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/2012","article-title":"Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts","volume":"4","author":"Park","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.sap.0000122857.49274.8c","article-title":"Use of topical sRAGE in diabetic wounds increases neovascularization and granulation tissue formation","volume":"52","author":"Wear-Maggitti","year":"2004","journal-title":"Ann. Plast. Surg."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1164\/rccm.200707-1069OC","article-title":"Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury","volume":"178","author":"Zhang","year":"2008","journal-title":"Am. J. Respir. Care Med."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.placenta.2005.02.016","article-title":"Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nutritive stress","volume":"27","author":"Chekir","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1081\/PRG-120021068","article-title":"The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia","volume":"22","author":"Cooke","year":"2003","journal-title":"Hypertens. Pregnancy"},{"issue":"181","key":"10.1016\/j.clinbiochem.2009.11.002_bib14","first-page":"e1","article-title":"The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation","volume":"196","author":"Buhimschi","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1515\/JPM.2008.076","article-title":"Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation","volume":"36","author":"Romero","year":"2008","journal-title":"J. Perinat. Med."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1515\/JPM.2008.080","article-title":"Germanov\u00e1 A, Kouck\u00fd M et al. Detection of feto-maternal infection\/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study","volume":"36","author":"H\u00e1jek","year":"2008","journal-title":"J. Perinat. Med."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-0897.2008.00679.x","article-title":"Glycation end products, soluble receptor for advanced glycation end products and cytokines in diabetic and non-diabetic pregnancies","volume":"61","author":"Pertynska-Marczewska","year":"2009","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib18","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1097\/HJH.0b013e3283060c5c","article-title":"Endogenous soluble receptor for advanced glycation end products is increased in preeclampsia","volume":"26","author":"Fasshauer","year":"2008","journal-title":"J. Hypertens."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00365510500375230","article-title":"Oxidative stress and inflammation in pregnancy","volume":"66","author":"Fialov\u00e1","year":"2006","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000052913","article-title":"Lipid peroxidation and antioxidant status in maternal and cord blood","volume":"51","author":"Arikan","year":"2001","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejogrb.2005.02.022","article-title":"Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy","volume":"123","author":"Belo","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.siny.2006.04.003","article-title":"Immunology of normal pregnancy","volume":"11","author":"AAgaard-Tillery","year":"2006","journal-title":"Semin. Fetal. Neonatal. Med."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/08830180215017","article-title":"Immunological relationship between the mother and the fetus","volume":"21","author":"Szekeres-Bartho","year":"2002","journal-title":"Int. Rev. Immun."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib24","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/S0002-9378(99)70400-X","article-title":"Cytokine abundance in placental tissues evidence of inflammatory activation in gestational membranes with term and preterm parturition","volume":"181","author":"Keelan","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/molehr\/gag001","article-title":"Leukocyte density and pro-inflammatory expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term","volume":"9","author":"Osman","year":"2003","journal-title":"Mol. Human Reprod."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1095\/biolreprod66.2.445","article-title":"Immunolocalization of proinflammatory cytokines in mymetrium, cervix, and fetal membranes during human parturition at term","volume":"66","author":"Young","year":"2002","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jss.2007.07.014","article-title":"sRAGE is elevated in septic patients and associated with patients outcome","volume":"147","author":"Bopp","year":"2008","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib28","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/01.CCM.0000262386.32287.29","article-title":"Neutrophil \u2013 derived S100A12 in acute lung injury and respiratory distress syndrome","volume":"35","author":"Wittkowski","year":"2007","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.siny.2006.05.001","article-title":"Inflammation in preterm and term labour and delivery","volume":"11","author":"Romero","year":"2006","journal-title":"Semin. Fetal. Neonatal. Med."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/14767050701830514","article-title":"Amniotic fluid prostaglandin concentrations increase before the onset of spontaneous labor at term","volume":"21","author":"Lee","year":"2008","journal-title":"J. Matern. Fetal. Neonatal Med."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.metabol.2006.09.013","article-title":"Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans","volume":"56","author":"Jang","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib32","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/01.hjh.0000177535.45785.64","article-title":"Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension","volume":"23","author":"Geroldi","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1071-5576(02)00259-9","article-title":"Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells","volume":"10","author":"Xia","year":"2003","journal-title":"J. Soc. Gynecol. Investig."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib34","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1681\/ASN.2005010062","article-title":"Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy","volume":"16","author":"Forbes","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clinbiochem.2009.11.002_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.placenta.2007.11.001","article-title":"Uric acid as a pathogenic factor in preeclampsia","volume":"29","author":"Bainbridge","year":"2008","journal-title":"Placenta"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912009005116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912009005116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:32:39Z","timestamp":1757863959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912009005116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":35,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0009912009005116"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.11.002","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble receptor for advanced glycation end products in physiological and pathological pregnancy","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}